New Jersey 2022-2023 Regular Session

New Jersey Assembly Bill A4852

Introduced
11/14/22  
Refer
11/14/22  
Refer
1/23/23  

Caption

Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.

Companion Bills

NJ S3287

Same As Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.

Similar Bills

NJ A911

Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.

NJ A3224

Requires institutions of higher education to maintain supply of naloxone hydrochloride nasal spray for opioid overdose emergencies and permits emergency administration of naloxone hydrochloride nasal spray by licensed campus medical professionals and resident assistants.

NJ A4699

Requires institutions of higher education to have automatic external defibrillator on premises and maintain supply of naloxone hydrochloride.

NJ A4244

Requires institutions of higher education to maintain supply of naloxone hydrochloride nasal spray for opioid overdose emergencies and permits emergency administration of naloxone hydrochloride nasal spray by licensed campus medical professionals and resident assistants.

NJ S3287

Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.

NJ S899

Requires institutions of higher education to maintain supply of naloxone hydrochloride nasal spray for opioid overdose emergencies and permits emergency administration of naloxone hydrochloride nasal spray by licensed campus medical professionals and designated persons.

NJ S2803

Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.

CA SB234

Opioid antagonists: stadiums, concert venues, and amusement parks.